Category: Press Release - Page 5 - Psychedelic Alpha

Read more about the article Revive Therapeutics Announces Initiation of Novel Bucillamine Formulation Development

Revive Therapeutics Announces Initiation of Novel Bucillamine Formulation Development

Post published:August 22, 2023
Post category:Press Release

Read more about the article Psyence Group Announces Closing of Private Placement & Conclusion of Loan Agreement

Psyence Group Announces Closing of Private Placement & Conclusion of Loan Agreement

Post published:August 21, 2023
Post category:Press Release

Read more about the article COMPASS Pathways Announces Up to $285 Million Private Placement Financing Joined by Leading Healthcare Investors

COMPASS Pathways Announces Up to $285 Million Private Placement Financing Joined by Leading Healthcare Investors

Post published:August 16, 2023
Post category:Press Release

Read more about the article MIND CURE HEALTH INC. (TO BE RENAMED LNG ENERGY GROUP CORP.) ANNOUNCES COMPLETION OF BUSINESS COMBINATION TRANSACTION

MIND CURE HEALTH INC. (TO BE RENAMED LNG ENERGY GROUP CORP.) ANNOUNCES COMPLETION OF BUSINESS COMBINATION TRANSACTION

Post published:August 16, 2023
Post category:Press Release

Read more about the article FILAMENT HEALTH AND NASDAQ-LISTED SPAC JUPITER ACQUISITION CORP. ANNOUNCE FILING OF SEC REGISTRATION STATEMENT

FILAMENT HEALTH AND NASDAQ-LISTED SPAC JUPITER ACQUISITION CORP. ANNOUNCE FILING OF SEC REGISTRATION STATEMENT

Post published:August 15, 2023
Post category:Press Release

Read more about the article Clearmind Medicine Announces Collaboration with CTS Ltd., a Leading Pharmaceutical and Consumer Products Company

Clearmind Medicine Announces Collaboration with CTS Ltd., a Leading Pharmaceutical and Consumer Products Company

Post published:August 14, 2023
Post category:Press Release

Read more about the article Apex Labs announces the appointment of Chief Medical Officer & Chief Commercial Officer

Apex Labs announces the appointment of Chief Medical Officer & Chief Commercial Officer

Post published:August 10, 2023
Post category:Press Release

Read more about the article Optimi Health Announces CAD $3,000,000 Senior Debt Financing

Optimi Health Announces CAD $3,000,000 Senior Debt Financing

Post published:August 10, 2023
Post category:Press Release

Read more about the article Silo Pharma Engages Clarivate for Intellectual Property and Patent Management

Silo Pharma Engages Clarivate for Intellectual Property and Patent Management

Post published:August 10, 2023
Post category:Press Release

Read more about the article atai Life Sciences Reports Second Quarter 2023 Financial Results and Operational Highlights, and Announces Clinical Data from the Phase 1 Study of DMX-1002 (Ibogaine)

atai Life Sciences Reports Second Quarter 2023 Financial Results and Operational Highlights, and Announces Clinical Data from the Phase 1 Study of DMX-1002 (Ibogaine)

Post published:August 10, 2023
Post category:Press Release

End of content

No more pages to load

Psychedelic Alpha

Psychedelic Alpha is an independent newsletter and community that strives to empower a diverse constellation of individuals and organisations with the knowledge, network and nuance to make an impact within the field of psychedelic medicine and beyond

Quick Links

Newsletter

Insights and interviews delivered to your inbox. No spam, just valuable information.